ARTICLE | Financial News
Scios files shelf registration
January 19, 2001 8:00 AM UTC
SCIO, which is developing its Natrecor nesiritide recombinant B-type natriuretic peptide to treat congestive heart failure, filed a shelf registration covering the sale of up to $120 million worth of ...